BCM-0002 | 24452 | Infiltrating ductal carcinoma | | | | Negative | Negative | Negative | Wild Type | Wild Type | | | Distant Metastasis | 43.62 | Black or African American | No | Anastrozole,Capecitabine,Carboplatin,Docetaxel,Doxorubicin,Gemcitabine,Letrozole,Paclitaxel,Tamoxifen |
BCM-0046 | 2219 | Infiltrating duct carcinoma, NOS (8500/3) | | | | Negative | Negative | Negative | Wild Type | Wild Type | IIB | | Primary | 53.44 | Hispanic or Latino | No | Cyclophosphamide,Docetaxel,Epirubicin |
BCM-0104 | 24561 | Infiltrating duct carcinoma, NOS (8500/3) | | | | Negative | Negative | Negative | Not Reported | Not Reported | IIIB | G3 (Poorly Differentiated) | Primary | 58.11 | White | No | Paclitaxel |
BCM-0113 | 4661 | Infiltrating duct carcinoma, NOS (8500/3) | | | | Negative | Negative | Negative | Wild Type | Wild Type | IIIC | G3 (Poorly Differentiated) | Distant Metastasis | 63.34 | Unknown | No | Capecitabine,Carboplatin,Cyclophosphamide,Docetaxel,Doxorubicin,Ixabepilone,Paclitaxel |
BCM-0132 | 28918 | Infiltrating duct carcinoma, NOS (8500/3) | | | | Negative | Negative | Negative | Wild Type | Wild Type | | G3 (Poorly Differentiated) | Primary | 58.88 | Black or African American | Yes | Capecitabine,Carboplatin,Cyclophosphamide,Docetaxel,Doxorubicin,Paclitaxel |
BCM-15003 | 14310 | Adenoid cystic carcinoma (8200/3) | | | | Negative | Negative | Negative | Not Reported | Not Reported | IA | | Primary | 66.33 | Hispanic or Latino | Yes | Cyclophosphamide,Docetaxel |
BCM-15006 | 13611+ | Adenocarcinoma, metastatic, NOS (8140/6) | | | | Negative | Negative | Negative | Wild Type | Wild Type | | G3 (Poorly Differentiated) | Primary | 33.91 | White | No | Capecitabine,Carboplatin,Cisplatin,Cyclophosphamide,Doxorubicin,Eribulin,Paclitaxel |
BCM-15008 | 25272 | Infiltrating duct carcinoma, NOS (8500/3) | | | | Negative | Negative | Negative | Not Reported | Not Reported | | G3 (Poorly Differentiated) | Distant Metastasis | 63.92 | White | No | Cisplatin,Cyclophosphamide,Docetaxel,Doxorubicin,Gemcitabine |
BCM-15029 | 32158 | Infiltrating duct carcinoma, NOS (8500/3) | | | | Negative | Negative | Negative | Wild Type | Wild Type | IA | G3 (Poorly Differentiated) | Second Primary | 46.87 | White,Hispanic or Latino | No | Carboplatin,Cyclophosphamide,Docetaxel,Doxorubicin |
BCM-15030 | 32323 | Infiltrating ductal carcinoma | | | | Positive | Positive | Negative | Wild Type | Wild Type | | | Distant Metastasis | 34.23 | White | No | Abemaciclib,Anastrozole,Capecitabine,Cyclophosphamide,Doxorubicin,Eribulin,Everolimus,Exemestane,Experimental Drugs,Fluorouracil,Fulvestrant,Goserelin,High-dose estrogen,Letrozole,Megestrol acetate,Other,Paclitaxel,Palbociclib,Tamoxifen |
BCM-15034 | 33355 | Infiltrating duct carcinoma, NOS (8500/3) | | | | Positive | Positive | Positive | Wild Type | Wild Type | Unknown | G3 (Poorly Differentiated) | Metastasis | 62.84 | White | No | Anastrozole,Capecitabine,Docetaxel,Eribulin,Everolimus,Exemestane,Letrozole,Paclitaxel,Palbociclib,Pertuzumab,Trastuzumab |
BCM-15046 | 13611+ | Adenocarcinoma, metastatic, NOS (8140/6) | | | | Negative | Negative | Negative | Wild Type | Wild Type | | G3 (Poorly Differentiated) | Distant Metastasis | 33.91 | White | No | Capecitabine,Carboplatin,Cisplatin,Cyclophosphamide,Doxorubicin,Eribulin,Paclitaxel |
BCM-15051 | 35624 | Carcinoma, NOS (8010/3) | | | | Negative | Negative | Negative | Not Reported | Not Reported | IIIB | | Primary | 59.38 | White | No | Capecitabine,Carboplatin,Cyclophosphamide,Doxorubicin,Paclitaxel |
BCM-15057 | 36302 | Infiltrating duct carcinoma, NOS (8500/3) | | | | Positive | Positive | Negative | Not Reported | Not Reported | IIIA | G3 (Poorly Differentiated) | Primary | 80.03 | Hispanic or Latino | No | Anastrozole,Exemestane,Paclitaxel |
BCM-15100 | 24590 | Infiltrating ductal carcinoma, NOS | | | | Positive | Positive | Negative | Wild Type | Wild Type | | | Distant Metastasis | 37.97 | White | No | Abemaciclib,Capecitabine,Carboplatin,Cyclophosphamide,Denosumab,Docetaxel,Doxorubicin,Eribulin,Fulvestrant,Letrozole,Leuprolide,Paclitaxel,Palbociclib,Stereotactic radiosurgery,Tamoxifen |